RHÖN-KLINIKUM Future Growth
Future criteria checks 1/6
RHÖN-KLINIKUM's revenue is forecast to decline at 2.6% per annum while its annual earnings are expected to grow at 7.2% per year. EPS is expected to grow by 6.8% per annum.
Key information
7.2%
Earnings growth rate
6.8%
EPS growth rate
Healthcare earnings growth | 20.9% |
Revenue growth rate | -2.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,605 | 52 | N/A | N/A | 1 |
12/31/2025 | 1,566 | 47 | N/A | N/A | 1 |
12/31/2024 | 1,520 | 43 | N/A | N/A | 1 |
3/31/2024 | 1,767 | 43 | N/A | N/A | N/A |
12/31/2023 | 1,735 | 39 | 46 | 109 | N/A |
9/30/2023 | 1,706 | 32 | N/A | N/A | N/A |
6/30/2023 | 1,688 | 26 | -36 | 18 | N/A |
3/31/2023 | 1,690 | 30 | N/A | N/A | N/A |
12/31/2022 | 1,661 | 25 | 2 | 60 | N/A |
9/30/2022 | 1,640 | 30 | N/A | N/A | N/A |
6/30/2022 | 1,628 | 32 | -18 | 48 | N/A |
3/31/2022 | 1,602 | 28 | N/A | N/A | N/A |
12/31/2021 | 1,591 | 28 | 20 | 98 | N/A |
9/30/2021 | 1,557 | 15 | N/A | N/A | N/A |
6/30/2021 | 1,554 | 14 | 23 | 117 | N/A |
3/31/2021 | 1,549 | 7 | N/A | N/A | N/A |
12/31/2020 | 1,546 | 1 | 16 | 113 | N/A |
9/30/2020 | 1,537 | 8 | 20 | 113 | N/A |
6/30/2020 | 1,532 | 19 | 10 | 100 | N/A |
3/31/2020 | 1,513 | 31 | -28 | 63 | N/A |
12/31/2019 | 1,481 | 43 | -67 | 47 | N/A |
9/30/2019 | 1,436 | 40 | -61 | 91 | N/A |
6/30/2019 | 1,413 | 52 | -95 | 74 | N/A |
3/31/2019 | 1,394 | 47 | -134 | 46 | N/A |
12/31/2018 | 1,390 | 49 | -114 | 50 | N/A |
9/30/2018 | 1,411 | 55 | -114 | 24 | N/A |
6/30/2018 | 1,385 | 36 | -76 | 54 | N/A |
3/31/2018 | 1,374 | 37 | -57 | 63 | N/A |
12/31/2017 | 1,362 | 35 | N/A | 80 | N/A |
9/30/2017 | 1,340 | 2 | N/A | 69 | N/A |
6/30/2017 | 1,330 | 4 | N/A | 87 | N/A |
3/31/2017 | 1,334 | 14 | N/A | 96 | N/A |
12/31/2016 | 1,319 | 56 | N/A | 109 | N/A |
9/30/2016 | 1,291 | 101 | N/A | 114 | N/A |
6/30/2016 | 1,276 | 105 | N/A | 101 | N/A |
3/31/2016 | 1,251 | 103 | N/A | 80 | N/A |
12/31/2015 | 1,240 | 85 | N/A | 67 | N/A |
9/30/2015 | 1,250 | 66 | N/A | 63 | N/A |
6/30/2015 | 1,248 | 62 | N/A | 54 | N/A |
3/31/2015 | 1,300 | -138 | N/A | 55 | N/A |
12/31/2014 | 1,666 | 1,226 | N/A | 49 | N/A |
9/30/2014 | 2,171 | 1,245 | N/A | 67 | N/A |
6/30/2014 | 2,661 | 1,250 | N/A | 153 | N/A |
3/31/2014 | 3,098 | 1,459 | N/A | 209 | N/A |
12/31/2013 | 3,223 | 87 | N/A | 210 | N/A |
9/30/2013 | 3,189 | 87 | N/A | 199 | N/A |
6/30/2013 | 3,167 | 90 | N/A | 171 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RHKU's forecast earnings growth (7.2% per year) is above the savings rate (0.7%).
Earnings vs Market: RHKU's earnings (7.2% per year) are forecast to grow slower than the German market (18.7% per year).
High Growth Earnings: RHKU's earnings are forecast to grow, but not significantly.
Revenue vs Market: RHKU's revenue is expected to decline over the next 3 years (-2.6% per year).
High Growth Revenue: RHKU's revenue is forecast to decline over the next 3 years (-2.6% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RHKU's Return on Equity is forecast to be high in 3 years time